Publications by authors named "O S Stern"

Alternative splicing (AS) is a mechanism that generates translational diversity within a genome. Equally important is the dynamic adaptability of the splicing machinery, which can give preference to one isoform over others encoded by a single gene. These isoform preferences change in response to the cell's state and function.

View Article and Find Full Text PDF

The ability of cells to manage consequences of exogenous proteotoxicity is key to cellular homeostasis. While a plethora of well-characterised machinery aids intracellular proteostasis, mechanisms involved in the response to denaturation of extracellular proteins remain elusive. Here we show that aggregation of protein ectodomains triggers their endocytosis via a macroendocytic route, and subsequent lysosomal degradation.

View Article and Find Full Text PDF
Article Synopsis
  • This phase 1 study examined the safety, tolerability, and effectiveness of FS118, a bispecific antibody targeting LAG-3 and PD-L1, in patients with advanced cancer who did not respond to anti-PD-(L)1 therapies.
  • A total of 43 patients received FS118 through an intravenous method, demonstrating good tolerance with no serious side effects, and a recommended dosage of 10 mg/kg was established.
  • The treatment resulted in a 46.5% disease control rate, primarily through stable disease, highlighting the potential for further research on its clinical benefits in resistant cancer cases.
View Article and Find Full Text PDF

Anaplastic thyroid cancer represents a rare, highly aggressive form of thyroid cancer with a poor prognosis and an overall survival ranging from 5 to 12 months. Unfortunately, treatment options remain limited, even for patients with a targetable driver mutation. Here, we present a case of a patient with a BRAF V600E-mutated, PD-L1 positive (tumor proportion score of 95%) anaplastic thyroid cancer refractory to standard therapies, including debulking surgery, followed by chemoradiation, who had further progressed on PD-1 monotherapy, and was unable to tolerate BRAF/MEK inhibition.

View Article and Find Full Text PDF

Background: The abdominal wall expanding system (AWEX) was first applied in 2012 and published in 2017. This novel technique was developed to reconstruct complex incisional hernias and residual skin-grafted laparostoma after treatment of an open abdomen, when primary midline closure was impossible. The main aim was the anatomical reconstruction of the abdominal wall and the avoidance of dissecting techniques (component separation).

View Article and Find Full Text PDF